Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/21/2026, 12:24:00 PM
Content snapshot
{ "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7_task_73907230", "round_number": 4, "agent_persona": "persona-synthesizer", "agent_backend": "scidex.core.llm.complete", "action": "synthesize", "content": "{\n \"ranked_hypotheses\": [\n {\n \"title\": \"TBK1-OPTN-NDP52 Phospho-Cascade Coordinates Multi-Organelle Autophagy\",\n \"description\": \"TBK1 phosphorylates OPTN (Ser177) and NDP52 (Ser67), enhancing ubiquitin-binding affinity for damaged organelles. This phospho-cascade acts as a 'broadcast hub' enabling simultaneous clearance of mitochondria via OPTN and ER fragments via NDP52. ALS-associated loss-of-function mutations impair multi-organelle quality control, providing human genetic validation. Pharmacologically targetable via kinase inhibitors with established medicinal chemistry precedent.\",\n \"target_gene\": \"TBK1, OPTN (TBC1D7), NDP52/CALCOCO2\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.78,\n \"novelty\": 0.72,\n \"feasibility\": 0.82,\n \"therapeutic_potential\": 0.85,\n \"mechanistic_plausibility\": 0.74,\n \"druggability\": 0.88,\n \"safety_profile\": 0.68,\n \"competitive_landscape\": 0.70,\n \"data_availability\": 0.80,\n \"reproducibility\": 0.75\n },\n \"composite_score\": 0.772,\n \"evidence_for\": [\n {\"claim\": \"TBK1 phosphorylates OPTN Ser177 enhancing mitophagy\", \"pmid\": \"24592263\"},\n {\"claim\": \"TBK1 mutations cause ALS with impaired mitophagy\", \"pmid\": \"24951150\"},\n {\"claim\": \"NDP52 recruits autophagy to damaged mitochondria independently of parkin\", \"pmid\": \"25985789\"},\n {\"claim\": \"OPTN mediates ER-phagy under starvation\", \"pmid\": \"32048902\"},\n {\"claim\": \"TBK1 activity required for general selective autophagy\", \"pmid\": \"25556504\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"ER-targeting of receptors under disease conditions underexplored\", \"pmid\": null},\n {\"claim\": \"TBK1 mutations show tissue-specific phenotypes, challenging 'global coordinator' model\", \"pmid\": null},\n {\"claim\": \"Direct NDP52 engagement of ER vesicles lacks validation\", \"pmid\": \"25985789\"}\n ]\n },\n {\n \"title\": \"TFEB/TFE3 Parallel Activation Drives Coordinated Organelle Clearance via CLEAR Network\",\n \"description\": \"mTORC1 inhibition or AMPK activation triggers nuclear translocation of TFEB/TFE3, which co-regulate both shared autophagy-lysosome genes and organelle-specific programs (PRKN for mitophagy, FAM134B for reticulophagy). Heterodimerization creates a feedforward loop coordinating multi-organelle quality control. TFEB overexpression rescues mitochondrial and ER stress in PD models.\",\n \"target_gene\": \"TFEB (TFEB), TFE3 (TFE3), mTORC1 (MTOR)\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.70,\n \"novelty\": 0.75,\n \"feasibility\": 0.76,\n \"therapeutic_potential\": 0.82,\n \"mechanistic_plausibility\": 0.68,\n \"druggability\": 0.72,\n \"safety_profile\": 0.62,\n \"competitive_landscape\": 0.78,\n \"data_availability\": 0.74,\n \"reproducibility\": 0.70\n },\n \"composite_score\": 0.727,\n \"evidence_for\": [\n {\"claim\": \"TFEB/TFE3 double KO causes severe neurodegeneration\", \"pmid\": \"31801954\"},\n {\"claim\": \"TFEB overexpression rescues mitochondrial and ER stress in PD models\", \"pmid\": \"29311652\"},\n {\"claim\": \"TFE3 drives reticulophagy via ER stress response\", \"pmid\": \"29045917\"},\n {\"claim\": \"CLEAR network encompasses >400 autophagy-lysosome genes\", \"pmid\": \"26942069\"},\n {\"claim\": \"TFE3 can compensate for TFEB loss\", \"pmid\": \"31501761\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"Double KO could reflect general lysosomal failure, not specific coordination loss\", \"pmid\": \"31801954\"},\n {\"claim\": \"TFEB/TFE3 promoter binding divergence unproven in neurons\", \"pmid\": null},\n {\"claim\": \"Heterodimerization evidence is indirect\", \"pmid\": null}\n ]\n },\n {\n \"title\": \"p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle Cargo for Coordinated Autophagy\",\n \"description\": \"p62 undergoes LLPS upon phosphorylation (Ser403) and ubiquitination of bound cargo, forming droplets that concentrate ubiquitinated proteins from multiple organelles (mitochondria, ER, protein aggregates) into a single autophagosomal capture event. This 'mixed garbage collection' allows coordinated multi-organelle clearance. The Keap1-p62 axis also links autophagy to NRF2 antioxidant response.\",\n \"target_gene\": \"SQSTM1/p62 (SQSTM1), ULK1/FIP200\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.68,\n \"novelty\": 0.85,\n \"feasibility\": 0.58,\n \"therapeutic_potential\": 0.65,\n \"mechanistic_plausibility\": 0.68,\n \"druggability\": 0.45,\n \"safety_profile\": 0.60,\n \"competitive_landscape\": 0.80,\n \"data_availability\": 0.65,\n \"reproducibility\": 0.55\n },\n \"composite_score\": 0.649,\n \"evidence_for\": [\n {\"claim\": \"p62 LLPS required for selective autophagy\", \"pmid\": \"31439799\"},\n {\"claim\": \"p62 body formation captures both mitochondria and ER in neuroprotection\", \"pmid\": \"31506447\"},\n {\"claim\": \"Keap1-p62 axis links autophagy to NRF2 antioxidant response\", \"pmid\": \"27459026\"},\n {\"claim\": \"p62 deletion causes mitochondrial and ER dysfunction in mice\", \"pmid\": \"30626971\"},\n {\"claim\": \"p62 phosphorylated at Ser403 by CK2/TBK1 enhances aggregate clearance\", \"pmid\": \"23842799\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"Individual p62 droplets containing both organelles unproven - could be adjacent separate droplets\", \"pmid\": \"31506447\"},\n {\"claim\": \"Different ubiquitin chain types may partition organelles into distinct droplets\", \"pmid\": null},\n {\"claim\": \"p62's primary function may be aggregate clearance, not dynamic organelle QC\", \"pmid\": null}\n ]\n },\n {\n \"title\": \"ER-Mitochondria Calcium Microdomains Couple Mitophagy and ER-Phagy Initiation\",\n \"description\": \"ER calcium release via IP3R1 at MAMs creates local microdomains that activate mitochondria-localized dehydrogenases. Severe calcium overload sensitizes mitochondria for mitophagy via ROS and membrane potential collapse, while ER calcium depletion triggers IRE1α/PERK-mediated ER-phagy. This metabolic coupling synchronizes clearance of both organelles.\",\n \"target_gene\": \"ITPR1 (IP3R1), VDAC1, MCU\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.65,\n \"novelty\": 0.68,\n \"feasibility\": 0.62,\n \"therapeutic_potential\": 0.58,\n \"mechanistic_plausibility\": 0.60,\n \"druggability\": 0.70,\n \"safety_profile\": 0.52,\n \"competitive_landscape\": 0.75,\n \"data_availability\": 0.68,\n \"reproducibility\": 0.58\n },\n \"composite_score\": 0.636,\n \"evidence_for\": [\n {\"claim\": \"ER-mitochondria calcium transfer drives mitophagy\", \"pmid\": \"25895059\"},\n {\"claim\": \"IRE1α activation induces ER-phagy via FAM134B\", \"pmid\": \"28609667\"},\n {\"claim\": \"PERK activation leads to reticulophagy\", \"pmid\": \"29339433\"},\n {\"claim\": \"VDAC1 oligomerization induced by calcium mediates mitophagy\", \"pmid\": \"29162697\"},\n {\"claim\": \"IP3R1 dysfunction in Huntington's disease impairs organelle crosstalk\", \"pmid\": \"28666991\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"Calcium-induced mitophagy involves mPTP opening - lethal signal, not QC\", \"pmid\": \"25895059\"},\n {\"claim\": \"Temporal sequence of coordination is unclear\", \"pmid\": null},\n {\"claim\": \"IP3R1 dysfunction effects on ER-phagy are inferred, not measured\", \"pmid\": \"28666991\"}\n ]\n },\n {\n \"title\": \"MFN2-PACS2 Axis at MAMs Coordinates Mitophagy-ER-Phagy Sync\",\n \"description\": \"MFN2 anchors mitochondria to ER at MAMs; upon mitochondrial stress, MFN2 remodels contact sites positioning mitophagy receptors near ER-sourced membranes while PACS2-regulated calcium microdomains trigger organelle-specific autophagosome nucleation. Disrupting this axis collapses coordinated quality control.\",\n \"target_gene\": \"MFN2 (MFN2), PACS2 (PACS2)\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.60,\n \"novelty\": 0.72,\n \"feasibility\": 0.58,\n \"therapeutic_potential\": 0.55,\n \"mechanistic_plausibility\": 0.58,\n \"druggability\": 0.52,\n \"safety_profile\": 0.65,\n \"competitive_landscape\": 0.78,\n \"data_availability\": 0.62,\n \"reproducibility\": 0.55\n },\n \"composite_score\": 0.615,\n \"evidence_for\": [\n {\"claim\": \"MFN2 physically interacts with LC3 via LIR motif; knockdown impairs mitophagy\", \"pmid\": \"31171695\"},\n {\"claim\": \"PACS2 regulates ER-mitochondria tethering and calcium homeostasis\", \"pmid\": \"25437556\"},\n {\"claim\": \"MAM integrity compromised in ALS/PD patient neurons\", \"pmid\": \"31641032\"},\n {\"claim\": \"ER contributes membranes to autophagosomes via WIPI2/PI3KC3 during selective autophagy\", \"pmid\": \"25648100\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"MFN2 LIR functionality varies by context; may impair mitophagy via fusion defects, not receptor function\", \"pmid\": \"31171695\"},\n {\"claim\": \"PACS2 connection to mitophagy initiation is inferential, not causal\", \"pmid\": \"25437556\"},\n {\"claim\": \"MAM disruption may be downstream effect, not driver of coordination failure\", \"pmid\": \"31641032\"}\n ]\n },\n {\n \"title\": \"VPS34 Complex I Subunit Heterogeneity Dictates Organelle-Specific vs. Bulk Autophagy\",\n \"description\": \"VPS34 forms complex I with ATG14L for omegasome/ER recruitment, but different regulatory subunits (UVRAG, BIF1, NRBF2) direct specificity. NRBF2 recruits VPS34 to mitochondria-ER contact sites, enabling condition-specific switching between mitophagy, ER-phagy, and general autophagy based on cellular need.\",\n \"target_gene\": \"PIK3C3/VPS34, ATG14L, UVRAG, NRBF2\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.55,\n \"novelty\": 0.65,\n \"feasibility\": 0.52,\n \"therapeutic_potential\": 0.50,\n \"mechanistic_plausibility\": 0.52,\n \"druggability\": 0.58,\n \"safety_profile\": 0.55,\n \"competitive_landscape\": 0.72,\n \"data_availability\": 0.60,\n \"reproducibility\": 0.52\n },\n \"composite_score\": 0.571,\n \"evidence_for\": [\n {\"claim\": \"NRBF2 recruits VPS34 to mitochondria-ER contact sites\", \"pmid\": \"27840058\"},\n {\"claim\": \"UVRAG mutations impair autophagy and cause neurodegeneration\", \"pmid\": \"25985789\"},\n {\"claim\": \"ATG14L required for ER-implicated autophagosome biogenesis\", \"pmid\": \"19050071\"},\n {\"claim\": \"PI3P at ER initiates both general and selective autophagy\", \"pmid\": \"25648100\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"PI3P signaling is generic; doesn't determine organelle specificity\", \"pmid\": \"25648100\"},\n {\"claim\": \"VPS34 inhibitors block general autophagy without selectivity\", \"pmid\": null},\n {\"claim\": \"Complex composition may be constitutive, not dynamically regulated\", \"pmid\": null}\n ]\n },\n {\n \"title\": \"NAD+/SARM1 Axis Provides Metabolic Feedback Coupling Mitophagy to ER-Phagy\",\n \"description\": \"SARM1 activation consumes NAD+ during axonal injury, activating mitophagy via PARP1 inhibition freeing SIRT1/SIRT3 deacetylases while triggering ER stress and compensatory ER-phagy. This metabolic coupling ensures coordinated organelle quality control during metabolic crisis.\",\n \"target_gene\": \"SARM1 (SARM1), PARP1, SIRT1, SIRT3\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.52,\n \"novelty\": 0.70,\n \"feasibility\": 0.50,\n \"therapeutic_potential\": 0.58,\n \"mechanistic_plausibility\": 0.48,\n \"druggability\": 0.65,\n \"safety_profile\": 0.58,\n \"competitive_landscape\": 0.72,\n \"data_availability\": 0.55,\n \"reproducibility\": 0.50\n },\n \"composite_score\": 0.578,\n \"evidence_for\": [\n {\"claim\": \"SARM1 activation induces rapid axonal degeneration via NAD+ depletion\", \"pmid\": \"30209461\"},\n {\"claim\": \"SIRT3 deacetylates SOD2 and OPA1 to enhance mitophagy\", \"pmid\": \"26109801\"},\n {\"claim\": \"NAD+ restoration protects against neurodegenerative models\", \"pmid\": \"28749327\"},\n {\"claim\": \"NMN supplementation improves organelle quality in aging neurons\", \"pmid\": \"30341063\"}\n ],\n \"evidence_against\": [\n {\"claim\": \"SARM1 is injury-activated, not disease-relevant in chronic neurodegeneration\", \"pmid\": \"30209461\"},\n {\"claim\": \"NAD+ depletion is general stress signal; specific coordination mechanism unclear\", \"pmid\": null},\n {\"claim\": \"SARM1 KO neuroprotective in injury but doesn't prevent all neurodegenerative pathology\", \"pmid\": null}\n ]\n }\n ],\n \"knowledge_edges\": [\n {\"source_id\": \"TBK1\", \"source_type\": \"gene\", \"target_id\": \"TBK1-OPTN-NDP52\", \"target_type\": \"hypothesis\", \"relation\": \"central_regulator\"},\n {\"source_id\": \"OPTN\", \"source_type\": \"gene\", \"target_id\": \"TBK1-OPTN-NDP52\", \"target_type\": \"hypothesis\", \"relation\": \"cargo_receptor\"},\n {\"source_id\": \"NDP52\", \"source_type\": \"gene\", \"target_id\": \"TBK1-OPTN-NDP52\", \"target_type\": \"hypothesis\", \"relation\": \"cargo_receptor\"},\n {\"source_id\": \"TFEB\", \"source_type\": \"gene\", \"target_id\": \"TFEB/TFE3\", \"target_type\": \"hypothesis\", \"relation\": \"transcription_factor\"},\n {\"source_id\": \"TFE3\", \"source_type\": \"gene\", \"target_id\": \"TFEB/TFE3\", \"target_type\": \"hypothesis\", \"relation\": \"transcription_factor\"},\n {\"source_id\": \"MTOR\", \"source_type\": \"gene\", \"target_id\": \"TFEB/TFE3\", \"target_type\": \"hypothesis\", \"relation\": \"upstream_regulator\"},\n {\"source_id\": \"SQSTM1\", \"source_type\": \"gene\", \"target_id\": \"p62_LLPS\", \"target_type\": \"hypothesis\", \"relation\": \"scaffold_protein\"},\n {\"source_id\": \"p62_LLPS\", \"source_type\": \"hypothesis\", \"target_id\": \"TBK1-OPTN-NDP52\", \"target_type\": \"hypothesis\", \"relation\": \"converges_on_shared_mechanism\"},\n {\"source_id\": \"MFN2\", \"source_type\": \"gene\", \"target_id\": \"MFN2-PACS2\", \"target_type\": \"hypothesis\", \"relation\": \"mitochondrial_fusion_receptor\"},\n {\"source_id\": \"PACS2\", \"source_type\": \"gene\", \"target_id\": \"MFN2-PACS2\", \"target_type\": \"hypothesis\", \"relation\": \"ER_regulator\"},\n {\"source_id\": \"ITPR1\", \"source_type\": \"gene\", \"target_id\": \"Calcium_signaling\", \"target_type\": \"hypothesis\", \"relation\": \"calcium_release_channel\"},\n {\"source_id\": \"MCU\", \"source_type\": \"gene\", \"target_id\": \"Calcium_signaling\", \"target_type\": \"hypothesis\", \"relation\": \"mitochondrial_calcium_uptake\"},\n {\"source_id\": \"PIK3C3\", \"source_type\": \"gene\", \"target_id\": \"VPS34_complexes\", \"target_type\": \"hypothesis\", \"relation\": \"lipid_kinase\"},\n {\"source_id\": \"SARM1\", \"source_type\": \"gene\", \"target_id\": \"NAD_SARM1\", \"target_type\": \"hypothesis\", \"relation\": \"NADase_enzyme\"},\n {\"source_id\": \"SIRT3\", \"source_type\": \"gene\", \"target_id\": \"NAD_SARM1\", \"target_type\": \"hypothesis\", \"relation\": \"mitochondrial_deacetylase\"}\n ],\n \"synthesis_summary\": \"The debate synthesis reveals a consensus that TBK1-OPTN-NDP52 phospho-cascade (composite score 0.772) represents the most promising therapeutic target for coordinating organelle-specific autophagy in neurodegeneration, supported by human genetics (ALS LOF mutations), established kinase inhibitor precedent, and dual-organelle targeting potential. The Skeptic's critical revisions appropriately identified experimental gaps—particularly the underexplored ER-targeting of receptors and tissue-specific phenotype concerns—reducing original confidence from 0.81 to 0.68 while maintaining priority ranking. TFEB/TFE3 activation (0.727) emerges as a complementary strategy offering broader therapeutic applicability but weaker genetic specificity, making it suitable for indications lacking defined genetic cohorts. The Domain Expert's recommendation for a portfolio weighted 60/30/10 toward TBK1/TFEB/p62 aligns with the synthesized ranking, though p62 phase separation requires critical STORM validation of hetero-organellar droplet formation before investment, as reproducibility remains a significant concern (0.55).\"\n}", "tokens_used": "4010", "persona_id": "persona-synthesizer" }